The use of HbA1c for new diagnosis of diabetes in those with hyperglycaemia on admission to or attendance at hospital urgently requires research
The use of HbA1c for new diagnosis of diabetes in those with hyperglycaemia on admission to or attendance at hospital urgently requires research
The prevalence of diabetes in Birmingham is 11% but it is 22% in hospital inpatients. Queen Elizabeth Hospital in Birmingham (QEHB) serves a multi-ethnic population with 6% Afro-Caribbean, 19% South Asian and 70% White European. A clinical audit of 18,965 emergency admissions to QEHB showed that 5% were undiagnosed but had admission glucose in the ‘diabetes’ range and 16% were in the ‘at risk’ range. The proportion of Afro-Caribbeans (7%) and South Asians (8%) in the ‘diabetes’ range was higher than White Europeans (5%). Given the magnitude of the problem, this paper explores the issues concerning the use of reflex HbA1c testing in the UK for diagnosis of diabetes in hospital admissions. HbA1c testing is suitable for most patients but conditions affecting red blood cell turnover invalidate the results in a small number of people. However, there are pertinent questions relating to the introduction of such testing in the NHS on a routine basis. Literature searches on a topical question ‘Is hyperglycaemia identified during emergency admission/attendance acted upon?’, were performed from 2016 to 2021 and 2016 to 2022. They identified 21 different, relevant, research papers - 5 from Australia, 9 from Europe including 4 from the UK, 5 from America and 1 each from Canada and Africa. These papers revealed an absence of established procedures for the management and follow-up of routinely detected hyperglycaemia using HbA1c when no previous diabetes diagnosis was recorded. Further work is required to determine the role of reflex HbA1c testing for diagnosis of diabetes in admissions with hyperglycaemia, and the cost-effectiveness and role of point-of-care HbA1c testing.
95-104
Manley, Susan E.
2c9d41f1-32fc-4891-9cc6-ea7c87487c20
Karwath, Andreas
7ebda210-745b-4574-b10a-45852faaa4be
Williams, John A.
2bb906ec-59c5-4da0-9bc2-f516b452baad
Stratton, Irene
772f25b9-23c0-4240-a3f6-1e76b03b172f
Roberts, Graham
3ed412f4-0e50-4a58-b958-d1cd55b72572
on behalf of the Diabetes Translational Research Group (DRTG), Queen Elizabeth Hospital Birmingham and Birmingham University
21 December 2022
Manley, Susan E.
2c9d41f1-32fc-4891-9cc6-ea7c87487c20
Karwath, Andreas
7ebda210-745b-4574-b10a-45852faaa4be
Williams, John A.
2bb906ec-59c5-4da0-9bc2-f516b452baad
Stratton, Irene
772f25b9-23c0-4240-a3f6-1e76b03b172f
Roberts, Graham
3ed412f4-0e50-4a58-b958-d1cd55b72572
Manley, Susan E., Karwath, Andreas and Williams, John A.
,
et al. and on behalf of the Diabetes Translational Research Group (DRTG), Queen Elizabeth Hospital Birmingham and Birmingham University
(2022)
The use of HbA1c for new diagnosis of diabetes in those with hyperglycaemia on admission to or attendance at hospital urgently requires research.
British Journal of Diabetes, 22 (2), .
(doi:10.15277/bjd.2022.386).
Abstract
The prevalence of diabetes in Birmingham is 11% but it is 22% in hospital inpatients. Queen Elizabeth Hospital in Birmingham (QEHB) serves a multi-ethnic population with 6% Afro-Caribbean, 19% South Asian and 70% White European. A clinical audit of 18,965 emergency admissions to QEHB showed that 5% were undiagnosed but had admission glucose in the ‘diabetes’ range and 16% were in the ‘at risk’ range. The proportion of Afro-Caribbeans (7%) and South Asians (8%) in the ‘diabetes’ range was higher than White Europeans (5%). Given the magnitude of the problem, this paper explores the issues concerning the use of reflex HbA1c testing in the UK for diagnosis of diabetes in hospital admissions. HbA1c testing is suitable for most patients but conditions affecting red blood cell turnover invalidate the results in a small number of people. However, there are pertinent questions relating to the introduction of such testing in the NHS on a routine basis. Literature searches on a topical question ‘Is hyperglycaemia identified during emergency admission/attendance acted upon?’, were performed from 2016 to 2021 and 2016 to 2022. They identified 21 different, relevant, research papers - 5 from Australia, 9 from Europe including 4 from the UK, 5 from America and 1 each from Canada and Africa. These papers revealed an absence of established procedures for the management and follow-up of routinely detected hyperglycaemia using HbA1c when no previous diabetes diagnosis was recorded. Further work is required to determine the role of reflex HbA1c testing for diagnosis of diabetes in admissions with hyperglycaemia, and the cost-effectiveness and role of point-of-care HbA1c testing.
This record has no associated files available for download.
More information
Published date: 21 December 2022
Identifiers
Local EPrints ID: 487015
URI: http://eprints.soton.ac.uk/id/eprint/487015
ISSN: 2397-6233
PURE UUID: fd49920b-8b40-467e-9154-2e9e5aa24f59
Catalogue record
Date deposited: 09 Feb 2024 17:41
Last modified: 13 Dec 2024 03:01
Export record
Altmetrics
Contributors
Author:
Susan E. Manley
Author:
Andreas Karwath
Author:
John A. Williams
Author:
Irene Stratton
Author:
Graham Roberts
Corporate Author: et al.
Corporate Author: on behalf of the Diabetes Translational Research Group (DRTG), Queen Elizabeth Hospital Birmingham and Birmingham University
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics